Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Silence Therapeutics to Present at Jefferies Global Healthcare Conference


Silence Therapeutics plc, Nasdaq: SLN ("Silence" or the "Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision engineered medicines, today announced the Company will present at the Jefferies Global Healthcare Conference on Thursday, June 6th at 2:30 p.m. ET.

The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.

About Silence Therapeutics
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet need. Silence's proprietary mRNAi GOLDtm platform can be used to create siRNAs (short interfering RNAs) that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include zerlasiran designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with high levels of lipoprotein(a) and divesiran designed to address rare hematological diseases, including polycythemia vera. Silence also maintains ongoing research and development collaborations with AstraZeneca and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.


These press releases may also interest you

at 18:30
Podcast Architects, a leading provider of B2B Podcasting Services, is excited to announce that it will operate under the new name "Proclaim", effective June 24,...

at 18:25
The global 3D scanner market size is estimated to grow by USD 4.68 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 11.68%  during the forecast period. The 3D scanner market is booming, fueled by the...

at 18:21
Product Creation Studio (PCS), a premier provider of engineering and design services, is excited to announce a new partnership with PatchClamp Medtech Inc. (PMI). This collaboration focuses on developing PatchClamp's novel dural repair graft...

at 18:20
The global wearable patch market  size is estimated to grow by USD 7.11 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 13.26%  during the forecast period.  ...

at 18:15
The global online survey software market size is estimated to grow by USD 5.56 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of about 13.21%  during the forecast period. ...

at 18:14
Iberia Advisory LLC (Iberia), a trusted provider of automation, data analytics, change management, program management, and financial management (FM) services, is pleased to announce its recent win as an awardee on the Department of the Navy's Small...



News published on and distributed by: